Mestag Therapeutics
Eilidh Goodwin is an accomplished finance professional with extensive experience in various roles across multiple organizations. Currently serving as the Director of Finance at Mestag Therapeutics since July 2022, Eilidh previously held positions at Horizon Discovery from August 2016 to June 2022, including Global Senior Finance Business Partner and Group Financial Reporting Manager. Eilidh's career also includes experience as an Audit Manager at Deloitte from September 2013 to July 2016 and as an Audit Senior at Peters Elworthy & Moore Limited from August 2009 to September 2013. Eilidh holds a Bachelor of Science degree in Accounting and Law from the University of East Anglia.
This person is not in any offices
Mestag Therapeutics
Mestag was founded in 2020 by leading investigators and SV Health Investors to develop new medicines for people affected by inflammatory disease and cancer.